Shanghai Henlius Biotech, Inc. (2696.HK)
HKD 40.35
(3.59%)
HKD 40.35
(3.59%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.00 CNY | 178.91% |
| 2022 | -1.28 CNY | 30.05% |
| 2021 | -1.83 CNY | 6.63% |
| 2020 | -1.96 CNY | -11.36% |
| 2019 | -1.76 CNY | -85.26% |
| 2018 | -0.95 CNY | -90.0% |
| 2017 | -0.50 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.36 CNY | 44.0% |
| 2024 Q2 | 0.36 CNY | 0.0% |
| 2023 FY | - CNY | 178.91% |
| 2023 Q1 | 0.22 CNY | 133.85% |
| 2023 Q4 | 0.25 CNY | -19.35% |
| 2023 Q3 | 0.31 CNY | 40.91% |
| 2023 Q2 | 0.22 CNY | 0.0% |
| 2022 Q4 | -0.65 CNY | -282.35% |
| 2022 Q3 | -0.17 CNY | 29.17% |
| 2022 Q2 | -0.24 CNY | 0.0% |
| 2022 Q1 | -0.24 CNY | 56.36% |
| 2022 FY | - CNY | 30.05% |
| 2021 Q3 | -0.55 CNY | -48.65% |
| 2021 Q2 | -0.37 CNY | 0.0% |
| 2021 Q1 | -0.37 CNY | 27.45% |
| 2021 FY | - CNY | 6.63% |
| 2021 Q4 | -0.55 CNY | 0.0% |
| 2020 FY | - CNY | -11.36% |
| 2020 Q4 | -0.51 CNY | 0.0% |
| 2020 Q2 | -0.43 CNY | 0.0% |
| 2020 Q1 | -0.43 CNY | 15.69% |
| 2020 Q3 | -0.51 CNY | -18.6% |
| 2019 Q4 | -0.51 CNY | 0.0% |
| 2019 Q2 | -0.33 CNY | -3.13% |
| 2019 Q1 | -0.32 CNY | 0.0% |
| 2019 FY | - CNY | -85.26% |
| 2019 Q3 | -0.51 CNY | -54.55% |
| 2018 Q4 | -0.32 CNY | -7.02% |
| 2018 FY | - CNY | -90.0% |
| 2018 Q3 | -0.30 CNY | -19.6% |
| 2018 Q2 | -0.25 CNY | -92.31% |
| 2018 Q1 | -0.13 CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | -8909.009% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | -55455.556% |